Bellerophon Therapeutics, Inc.·4

Jun 14, 4:39 PM ET

Tenenbaum Fabian 4

4 · Bellerophon Therapeutics, Inc. · Filed Jun 14, 2018

Insider Transaction Report

Form 4
Period: 2018-06-12
Tenenbaum Fabian
Chief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    2018-06-12$2.37/sh63,486$150,462254,983 total

Documents

1 file
  • 4
    wf-form4_152900874477421.xmlPrimary

    FORM 4